Becker Private Equity & Business Podcast

Latest Episodes
NVIDIA, Apple, & Healthcare Stocks 7-4-25
In this episode, Scott Becker discusses NVIDIA’s rapid rise toward a $4 trillion valuation, Apple’s modest recovery after early-year declines, and ongoing struggles among major healthcare stocks like
My Handicap is Real 7-4-25
In this episode, Scott shares a lighthearted anecdote about a colleague whose high golf handicap is often questioned despite being accurate.
Jobs Jump, Unemployment Falls 7-4-25
In this episode, Scott Becker discusses the latest jobs report and its impact on interest rate expectations.
Trump vs. Powell: Part Four 7-3-25
In this episode, Scott Becker discusses the ongoing tension between President Trump and Fed Chair Jerome Powell, highlighting Powells commitment to fighting inflation through sustained interest rates
The Tax Bill, Jobs Report, Trump vs. Powell, & More 7-3-25
In this episode, Scott Becker highlights six major stories including the potential passage of a major tax bill, a surprisingly strong jobs report, rising tensions between President Trump and Chairman
Centene Crashes 7-2-25
In this episode, Scott Becker discusses Centenes 40 percent stock drop following its announcement to stop providing financial guidance.
The Tax Bill Cometh 7-2-25
In this episode, Scott Becker breaks down the razor-thin passage of the new tax bill in the Senate and the high-stakes reconciliation process ahead in the House.
Saying No Is a Superpower 7-2-25
In this episode, Scott Becker explores the power of saying no as a way to regain focus, avoid burnout, and become more intentional in both business and life.
The Tax Bill Moves to the House + 6 More Stories We Are Following Today 7-2-25
In this episode, Scott Becker discusses the Senate passage of a major tax bill now heading to the House for a high-stakes reconciliation, alongside key updates on Centenes stock plunge, and more.
Current Private Equity Trends in Healthcare with Holly Buckley of McGuireWoods LLP 7-1-25
In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods, discusses a slowdown in mid-market activity, increased strategic exits, and regulatory developments shaping the second half of the